Zhang Zewen, Tian Tian, Chen Zhen, Liu Lirong, Luo Tao, Dai Jianghong
School of Public Health, Xinjiang Medical University, Urumqi, China.
PeerJ. 2021 Mar 24;9:e10952. doi: 10.7717/peerj.10952. eCollection 2021.
Gut microbiome has recently been identified as a new potential risk factor in addition to well-known diabetes risk factors. The aim of this study was to analyze the differences in the composition of gut microbiome in prediabetes(PreDM), type 2 diabetes mellitus (T2DM) and non-diabetic controls.
A total of 180 participants were recruited for this study: 60 with T2DM, 60 with PreDM and 60 non-diabetics (control group). Fecal samples were collected from the participants and genomic DNA was extracted. The composition and diversity of gut microbiome were investigated in fecal DNA samples using Illumina sequencing of the V3∼V4 regions of 16sRNA.
There were significant differences in the number of bacteria among patients with PreDM and T2DM and the control group. Compared with the control group, Proteobacteria bacteria were significantly higher in the PreDM group ( = 0.006). On the genus level, Compared with the control group, the relative abundance of Prevotella and Alloprevotella was significantly higher in the T2DM group ( = 0.016, = 0.018), and the relative abundance of Paraprevotella in T2DM and PreDM groups was lower than that in the control group ( = 0.011, = 0.045). Compared with the PreDM group and the control group, the relative abundance of Bacteroides in the T2DM group was significantly lower ( = 0.019, = 0.002).
The present study found significant differences in the gut microbiome between PreDM, T2DM and non-diabetic individuals, specifically at the genus level, suggesting that early intervention in PreDM patients could have implications for gut flora transitioning to T2DM. In addition, these results may be valuable for developing strategies to control T2DM by modifying the gut microbiome.
肠道微生物群最近被确定为除了众所周知的糖尿病风险因素之外的一种新的潜在风险因素。本研究的目的是分析糖尿病前期(PreDM)、2型糖尿病(T2DM)和非糖尿病对照组肠道微生物群组成的差异。
本研究共招募了180名参与者:60名T2DM患者、60名PreDM患者和60名非糖尿病患者(对照组)。从参与者中收集粪便样本并提取基因组DNA。使用16sRNA的V3∼V4区域的Illumina测序对粪便DNA样本中的肠道微生物群的组成和多样性进行研究。
PreDM和T2DM患者与对照组之间的细菌数量存在显著差异。与对照组相比,PreDM组中的变形菌门细菌显著更高(P = 0.006)。在属水平上,与对照组相比,T2DM组中普雷沃氏菌属和别普雷沃氏菌属的相对丰度显著更高(P = 0.016,P = 0.018),T2DM组和PreDM组中副普雷沃氏菌属的相对丰度低于对照组(P = 0.011,P = 0.045)。与PreDM组和对照组相比,T2DM组中拟杆菌属的相对丰度显著更低(P = 0.019,P = 0.002)。
本研究发现PreDM、T2DM和非糖尿病个体之间的肠道微生物群存在显著差异,特别是在属水平上,这表明对PreDM患者进行早期干预可能对肠道菌群向T2DM转变有影响。此外,这些结果对于通过改变肠道微生物群来制定控制T2DM的策略可能具有重要价值。